Loading
BT
BioVaxys Technology Corp. Stock: price and insider trades · Canada
BioVaxys Technology Corp.: what insiders have been doing
Every trade that managers of BioVaxys Technology Corp. disclose to SEDI is tracked on this page. Over the twelve months to 24 October 2026, 2 filings were filed, from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Compared with its exchange (2,734 companies, median 14 filings), a count of 2 filings is below the norm. Since 2024, the database holds 1 purchase and 2 sales by insiders of the company.
Insider buying of BioVaxys Technology Corp. has been absent for the past year.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€1,901
1 ops. · all time
Sell Volume
€537,945
2 ops. · all time
Who traded when
BuySaleJames Christopher Passin1 buy1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 20 November 2025
Declarations10 total
1,484,588 shares@ CA$0.1790.9% of flowCommon SharesTSXSEDI:4608731
148,468 shares@ CA$0.179.1% of flowCommon SharesTSXSEDI:4598449
8,417,576 sharesCommon SharesTSXSEDI:4578701
17,349,600 sharesCommon SharesTSXSEDI:4578364
100,000 shares@ CA$0.031.1% of flowCommon SharesTSXSEDI:4502859
Canonical exit: 27 Jul 2025 (T+90)
10,000,000 shares@ CA$0.0539.8% of flowCommon SharesTSXSEDI:4436200
10,000,000 shares@ CA$0.050339.9% of flowCommon SharesTSXSEDI:4436196
6,000,000 shares@ CA$0.05Common SharesTSXSEDI:4374198
5,000,000 shares@ CA$0.06Common SharesTSXSEDI:4374195
Common SharesTSXSEDI:4373481
10 of 10 declarations
About BioVaxys Technology Corp.
BioVaxys Technology Corp. is a company focused on developing therapeutic vaccines for the treatment of cancer and other diseases. It is listed on the Toronto Stock Exchange (XTSE).
